# Medical Properties Trust Inc: filings

MPT · NYSE · CIK 1287865 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/mpt.md) · [Financials](/companies/mpt/financials.md) · [Filings](/companies/mpt/filings.md) · [Insiders](/companies/mpt/insiders.md)

## Reports and events: 331 filings

Newest first, by EDGAR acceptance time (Eastern). Filter with ?form= one of: `periodic`, `8-K`, `10-K`, `10-Q`, `4`, `proxy`, `13dg`, `all`, or any form this company filed (4 436, 8-K 228, SC 13G/A 59, 10-Q 53, 424B5 38, UPLOAD 37, 5 28, CORRESP 27, 424B2 23, DEFA14A 21, 4/A 20, 10-K 18, DEF 14A 18, FWP 15, 3 10, S-3ASR 9, SC 13G 9, ARS 8, 10-K/A 7, SCHEDULE 13G/A 7, 144 5, 8-K/A 5, S-8 5, SC TO-I/A 5, 3/A 2, EFFECT 2, SCHEDULE 13G 2, SC TO-I 2, 10-Q/A 1, 424B3 1, 424B7 1, NT 10-Q 1, POS AM 1, POSASR 1, PRE 14A 1, S-4 1, SC 13D/A 1).

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-08-10 | 17:23 ET | [8-K](/filings/0001193125-26-342713.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-26-342713 |
| 2026-08-10 | 16:52 ET | [10-Q](/filings/0001193125-26-342583.md) | Quarterly report, period 2026-06-30 | 0001193125-26-342583 |
| 2026-08-10 | 09:25 ET | [8-K](/filings/0001193125-26-341434.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-26-341434 |
| 2026-06-01 | 16:55 ET | [8-K](/filings/0001193125-26-251659.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-26-251659 |
| 2026-05-08 | 16:20 ET | [10-Q](/filings/0001193125-26-214700.md) | Quarterly report, period 2026-03-31 | 0001193125-26-214700 |
| 2026-04-30 | 08:20 ET | [8-K](/filings/0001193125-26-194165.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-194165 |
| 2026-04-13 | 16:36 ET | [DEF 14A](/filings/0001193125-26-152971.md) | Proxy statement, period 2026-04-13 | 0001193125-26-152971 |
| 2026-02-26 | 08:31 ET | [10-K](/filings/0001193125-26-073587.md) | Annual report, period 2025-12-31 | 0001193125-26-073587 |
| 2026-02-19 | 08:30 ET | [8-K](/filings/0001193125-26-058167.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-26-058167 |
| 2026-01-20 | 08:56 ET | [8-K](/filings/0001193125-26-016037.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-26-016037 |
| 2025-11-07 | 16:07 ET | [10-Q](/filings/0001193125-25-272324.md) | Quarterly report, period 2025-09-30 | 0001193125-25-272324 |
| 2025-10-30 | 08:36 ET | [8-K](/filings/0001193125-25-257549.md) | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-257549 |
| 2025-08-14 | 16:22 ET | [8-K](/filings/0001193125-25-180805.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-180805 |
| 2025-08-11 | 17:03 ET | [8-K](/filings/0001193125-25-178048.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-178048 |
| 2025-08-08 | 17:25 ET | [10-Q](/filings/0000950170-25-106022.md) | Quarterly report, period 2025-06-30 | 0000950170-25-106022 |
| 2025-07-31 | 08:30 ET | [8-K](/filings/0001193125-25-170123.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-170123 |
| 2025-06-03 | 16:59 ET | [8-K](/filings/0001193125-25-134173.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-25-134173 |
| 2025-05-09 | 17:06 ET | [10-Q](/filings/0000950170-25-068203.md) | Quarterly report, period 2025-03-31 | 0000950170-25-068203 |
| 2025-05-01 | 08:54 ET | [8-K](/filings/0001193125-25-109039.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-109039 |
| 2025-04-17 | 16:30 ET | [DEF 14A](/filings/0000950170-25-055431.md) | Proxy statement, period 2025-04-17 | 0000950170-25-055431 |
| 2025-03-03 | 17:01 ET | [10-K](/filings/0000950170-25-030989.md) | Annual report, period 2024-12-31 | 0000950170-25-030989 |
| 2025-02-27 | 08:30 ET | [8-K](/filings/0001193125-25-037671.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-25-037671 |
| 2025-02-18 | 17:25 ET | [8-K](/filings/0001193125-25-028746.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-25-028746 |
| 2025-01-31 | 17:25 ET | [8-K](/filings/0001193125-25-018490.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-018490 |
| 2025-01-29 | 09:22 ET | [8-K](/filings/0001193125-25-015022.md) | 7.01 Regulation FD disclosure; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-25-015022 |
| 2024-11-13 | 17:09 ET | [10-Q/A](/filings/0000950170-24-126476.md) | Quarterly report, amended, period 2024-09-30 | 0000950170-24-126476 |
| 2024-11-12 | 17:00 ET | [10-Q](/filings/0000950170-24-125623.md) | Quarterly report, period 2024-09-30 | 0000950170-24-125623 |
| 2024-11-07 | 08:49 ET | [8-K](/filings/0001193125-24-252717.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-252717 |
| 2024-09-17 | 17:22 ET | [8-K](/filings/0001193125-24-220733.md) | 1.02 Termination of a material agreement; 2.06 Material impairments; 9.01 Financial statements and exhibits | 0001193125-24-220733 |
| 2024-08-09 | 17:10 ET | [10-Q](/filings/0000950170-24-094888.md) | Quarterly report, period 2024-06-30 | 0000950170-24-094888 |
| 2024-08-08 | 08:38 ET | [8-K](/filings/0001193125-24-196518.md) | 1.01 Entry into a material agreement; 2.02 Results of operations; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001193125-24-196518 |
| 2024-06-03 | 16:15 ET | [8-K](/filings/0001193125-24-153035.md) | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-24-153035 |
| 2024-05-29 | 16:09 ET | [10-Q](/filings/0000950170-24-065929.md) | Quarterly report, period 2024-03-31 | 0000950170-24-065929 |
| 2024-05-29 | 16:06 ET | [8-K/A](/filings/0001193125-24-149138.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-149138 |
| 2024-05-28 | 21:52 ET | [8-K](/filings/0001193125-24-147330.md) | 2.03 New direct financial obligation | 0001193125-24-147330 |
| 2024-05-16 | 16:48 ET | [8-K](/filings/0001193125-24-140662.md) | 3.01 Delisting notice; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-140662 |
| 2024-05-10 | 17:31 ET | [8-K](/filings/0001193125-24-136307.md) | 2.06 Material impairments | 0001193125-24-136307 |
| 2024-05-09 | 09:08 ET | [8-K](/filings/0001193125-24-134847.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-134847 |
| 2024-05-07 | 17:21 ET | [8-K](/filings/0001193125-24-133302.md) | 8.01 Other events | 0001193125-24-133302 |
| 2024-04-18 | 17:30 ET | [8-K](/filings/0001193125-24-100968.md) | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.01 Completion of an acquisition or disposition; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-100968 |
| 2024-04-17 | 17:01 ET | [DEF 14A](/filings/0001193125-24-099222.md) | Proxy statement, period 2024-05-30 | 0001193125-24-099222 |
| 2024-03-14 | 17:08 ET | [8-K](/filings/0001193125-24-068020.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-24-068020 |
| 2024-02-29 | 17:08 ET | [10-K](/filings/0000950170-24-023248.md) | Annual report, period 2023-12-31 | 0000950170-24-023248 |
| 2024-02-21 | 09:14 ET | [8-K](/filings/0001193125-24-040842.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-24-040842 |
| 2024-01-05 | 19:42 ET | [8-K](/filings/0001193125-24-002655.md) | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001193125-24-002655 |
| 2023-12-14 | 16:34 ET | [8-K](/filings/0001193125-23-295523.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-295523 |
| 2023-11-09 | 16:41 ET | [10-Q](/filings/0000950170-23-062169.md) | Quarterly report, period 2023-09-30 | 0000950170-23-062169 |
| 2023-10-26 | 09:00 ET | [8-K](/filings/0001193125-23-263599.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-263599 |
| 2023-08-09 | 17:11 ET | [10-Q](/filings/0000950170-23-040734.md) | Quarterly report, period 2023-06-30 | 0000950170-23-040734 |
| 2023-08-08 | 08:30 ET | [8-K](/filings/0001193125-23-205633.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001193125-23-205633 |

Page 1 of 7. [Older](/companies/mpt/filings.md?page=2)
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 08:19 ET. No prices; not investment advice.